Louis Vermeulen

Louis Vermeulen is a prominent figure in the field of oncology, currently serving as the Vice President and Senior Fellow, Head of Discovery Oncology at Genentech.12 He joined Genentech in this role in January 2023, where he oversees efforts to deepen the understanding of cancer biology and identify targets for new cancer drug development.2

Professional Background

Dr. Vermeulen holds dual positions:

1. At Genentech (since January 2023)
2. As a Professor of Molecular Oncology at Amsterdam UMC (since October 2017)1

Education and Training

Louis Vermeulen's educational background is extensive:

• MD and PhD from the University of Amsterdam
• Postdoctoral fellowship at the University of Cambridge, UK
• Trained as an internist and medical oncologist12

Research Focus

His research interests include:

• Cancer heterogeneity
• Dynamics of colorectal cancer development
• Drivers of early cancer development in various organs
• Crosstalk between cancer cells and their environment2

Previous Positions

Before joining Genentech, Dr. Vermeulen held several notable positions:

• Principal Investigator at AMC - Academisch Medisch Centrum (2014-Present)
• Medical Oncologist at AMC (2021-2023)
• Robinson Stem Cell Investigator at The New York Stem Cell Foundation Research Institute (2018-2023)1

Achievements and Expertise

Dr. Vermeulen is recognized for:

• His interdisciplinary approach combining fundamental research and clinical work
• Leadership in guiding PhD students and postdocs
• Contributions to understanding colorectal cancer, cancer stem cells, and Wnt signaling12

His LinkedIn profile (username: louisvermeulen) reflects his current roles and extensive experience in the field of oncology.1